Regulatory factors involved in Th17/Treg cell balance of immune thrombocytopenia

Abbasi, 2021, Prevalence of cytomegalovirus (CMV) and epstein-barr virus (EBV) subclinical infection in patients with acute immune thrombocytopenic purpura (ITP), Int. J. Hematol. Oncol. Stem Cell Res., 15, 139 Zhang, 2018, Immune dysregulation in primary immune thrombocytopenia patients, Hematology, 23, 510, 10.1080/10245332.2018.1435021 Cooper, 2021, Immune thrombocytopenia (ITP) World Impact Survey (iWISh): patient and physician perceptions of diagnosis, signs and symptoms, and treatment, Am. J. Hematol., 96, 188, 10.1002/ajh.26045 Kostic, 2020, CD4+ T cell phenotypes in the pathogenesis of immune thrombocytopenia, Cell. Immunol., 351, 10.1016/j.cellimm.2020.104096 Kistangari, 2013, Immune thrombocytopenia, Clin. Adv. Hematol. Oncol., 27, 495, 10.1016/j.hoc.2013.03.001 Zhou, 2005, Multi-dysfunctional pathophysiology in ITP, Crit. Rev. Oncol. Hematol., 54, 107, 10.1016/j.critrevonc.2004.12.004 Caza, 2015, Functional and phenotypic plasticity of CD4+ T cell subsets, Biomed. Res. Int., 2015, 10.1155/2015/521957 Semple J.W., Freedman J. Increased antiplatelet T helper lymphocyte reactivity in patients with autoimmune thrombocytopenia. 1991. Audia, 2021, Immune thrombocytopenia: recent advances in pathogenesis and treatments, Hemasphere, 5, 10.1097/HS9.0000000000000574 Zufferey, 2017, Pathogenesis and therapeutic mechanisms in immune thrombocytopenia (ITP), J. Clin. Med., 6, 16, 10.3390/jcm6020016 Hua, 2019, Aberrant expression of microRNA in CD4+ cells contributes to Th17/Treg imbalance in primary immune thrombocytopenia, Thromb. Res., 177, 70, 10.1016/j.thromres.2019.03.005 Cao, 2011, Imbalance of Th17/Treg cells ratio in peripheral blood of patients with immune thrombocytopenia, Zhongguo Shi Yan Xue Ye Xue Za Zhi, 19, 730 Gu, 2021, Increased proportion of Th17/Treg cells at the new diagnosed stage of chronic immune thrombocytopenia in pediatrics: the pilot study from a multi-center, Eur. J. Pediatr., 180, 3411, 10.1007/s00431-021-04121-z Ji, 2012, The ratio of Treg/Th17 cells correlates with the disease activity of primary immune thrombocytopenia, PLoS One, 7, e50909, 10.1371/journal.pone.0050909 Talaat, 2014, Alterations in immune cell subsets and their cytokine secretion profile in childhood idiopathic thrombocytopenic purpura (ITP), Clinic. Exp. Immunol., 176, 291, 10.1111/cei.12279 2016, T cells in the pathogenesis of immune thrombocytopenia Liu, 2016, Pulsed high-dose dexamethasone modulates Th1-/Th2-chemokine imbalance in immune thrombocytopenia, J. Transl. Med., 14, 1, 10.1186/s12967-016-1064-9 Yu, 2018, The transcription factor Bhlhe40 is a switch of inflammatory versus antiinflammatory Th1 cell fate determination, J. Exp. Med., 215, 1813, 10.1084/jem.20170155 Semple J.W., Milev Y., Cosgrave D., Mody M., Hornstein A., Blanchette V., et al. Differences in serum cytokine levels in acute and chronic autoimmune thrombocytopenic purpura: relationship to platelet phenotype and antiplatelet T-cell reactivity. 1996. Nakayama, 2017, Th2 cells in health and disease, Annu. Rev. Immunol., 35, 53, 10.1146/annurev-immunol-051116-052350 Kostić, 2020, Immunomodulatory effects of TGF-β in the patients with immune thrombocytopenia, Acta Med. Medianae, 59 Wang, 2005, Type 1 and type 2 T-cell profiles in idiopathic thrombocytopenic purpura, Haematologica, 90, 914 Ogawara, 2003, High Th1/Th2 ratio in patients with chronic idiopathic thrombocytopenic purpura, Eur. J. Haematol., 71, 283, 10.1034/j.1600-0609.2003.00138.x Panitsas, 2004, Adult chronic idiopathic thrombocytopenic purpura (ITP) is the manifestation of a type-1 polarized immune response, Blood, 103, 2645, 10.1182/blood-2003-07-2268 Takahashi, 2017, The cytokine polymorphisms affecting Th1/Th2 increase the susceptibility to, and severity of, chronic ITP, BMC Immunol., 18, 1, 10.1186/s12865-017-0210-3 Hu, 2011, Increased number of Tc17 and correlation with Th17 cells in patients with immune thrombocytopenia, PLoS One, 6, e26522, 10.1371/journal.pone.0026522 Kielsen, 2018, Reconstitution of Th17, Tc17 and Treg cells after paediatric haematopoietic stem cell transplantation: impact of interleukin-7, Immunobiology, 223, 220, 10.1016/j.imbio.2017.10.023 Singh, 2014, Th17 cells in inflammation and autoimmunity, Autoimmun. Rev., 13, 1174, 10.1016/j.autrev.2014.08.019 Damasceno, 2020, PKM2 promotes Th17 cell differentiation and autoimmune inflammation by fine-tuning STAT3 activation, J. Exp. Med., 217, 10.1084/jem.20190613 Shiomi, 2016, GM-CSF as a therapeutic target in autoimmune diseases, Inflamm. Regen., 36, 1, 10.1186/s41232-016-0014-5 Zielinski, 2014, Autoimmunity beyond Th17: GM-CSF producing T cells, Cell Cycle, 13, 2489, 10.4161/15384101.2014.946377 Goubran, 2018, Flow cytometry and immune thrombocytopenic purpura, Transfus Apher. Sci., 57, 800, 10.1016/j.transci.2018.10.018 Shevach, 2014, tTregs, pTregs, and iTregs: similarities and differences, Immunol. Rev., 259, 88, 10.1111/imr.12160 Vieyra-Lobato, 2018, Description of CD8+ regulatory T lymphocytes and their specific intervention in graft-versus-host and infectious diseases, autoimmunity, and cancer, J. Immunol. Res., 2018, 10.1155/2018/3758713 Yu, 2015, Inactivation of Notch signaling reverses the Th17/Treg imbalance in cells from patients with immune thrombocytopenia, Lab. Invest., 95, 157, 10.1038/labinvest.2014.142 Li, 2021, HUWE1 causes an immune imbalance in immune thrombocytopenic purpura by reducing the number and function of treg cells through the ubiquitination degradation of ets-1, Front. Cell Dev. Biol., 9 Aslam, 2012, Thymic retention of CD4+ CD25+ FoxP3+ T regulatory cells is associated with their peripheral deficiency and thrombocytopenia in a murine model of immune thrombocytopenia, Blood, 120, 2127, 10.1182/blood-2012-02-413526 Eggenhuizen, 2020, Treg enhancing therapies to treat autoimmune diseases, Int. J. Mol. Sci., 21, 7015, 10.3390/ijms21197015 Liu, 2018, Micro RNA-mediated regulation of T helper type 17/regulatory T-cell balance in autoimmune disease, Immunology, 155, 427, 10.1111/imm.12994 Jang, 2017, Casein kinase 2 is a critical determinant of the balance of Th17 and Treg cell differentiation, Exp. Mol. Med., 49, 10.1038/emm.2017.132 Zhou, 2016, Interleukin-17-producing CD4+ T lymphocytes are increased in patients with primary immune thrombocytopenia, Blood Coagul. Fibrinolysis, 27, 301, 10.1097/MBC.0000000000000423 Zhang, 2018, Circulating level of Th17 cells is associated with sensitivity to glucocorticoids in patients with immune thrombocytopenia, Int. J. Hematol., 107, 442, 10.1007/s12185-017-2392-0 Wang, 2019, Disrupted balance of CD4+ T-cell subsets in bone marrow of patients with primary immune thrombocytopenia, Int. J. Biol. Sci., 15, 2798, 10.7150/ijbs.33779 Zhang, 2017, Assessment of Th17/Treg cells and Th cytokines in an improved immune thrombocytopenia mouse model, Hematology, 22, 493 Arandi N., Mirshafiey A., J.E.D.D.I. TM, Shaghaghi M., Sadeghi B., Abolhassani H., et al. Alteration in frequency and function of CD4+ CD25+ FOXP3+ regulatory T cells in patients with immune thrombocytopenic purpura. 2014. Beringer, 2015, T cell receptor reversed polarity recognition of a self-antigen major histocompatibility complex, Nat. Immunol., 16, 1153, 10.1038/ni.3271 Hwang, 2020, Recent insights of T cell receptor-mediated signaling pathways for T cell activation and development, Exp. Mol. Med., 52, 750, 10.1038/s12276-020-0435-8 Bhattacharyya, 2020, Regulation of T helper cell fate by TCR signal strength, Front. Immunol., 11, 624, 10.3389/fimmu.2020.00624 Eken, 2019, Genetic deficiency and biochemical inhibition of ITK affect human Th17, Treg, and innate lymphoid cells, J. Clin. Immunol., 39, 391, 10.1007/s10875-019-00632-5 Gomez-Rodriguez, 2014, Itk-mediated integration of T cell receptor and cytokine signaling regulates the balance between Th17 and regulatory T cells, J. Exp. Med., 211, 529, 10.1084/jem.20131459 Olenchock, 2006, Disruption of diacylglycerol metabolism impairs the induction of T cell anergy, Nat. Immunol., 7, 1174, 10.1038/ni1400 Koonpaew, 2006, LAT-mediated signaling in CD4+ CD25+ regulatory T cell development, J. Exp. Med., 203, 119, 10.1084/jem.20050903 Takeuchi, 2020, Impaired T cell receptor signaling and development of T cell–mediated autoimmune arthritis, Immunol. Rev., 294, 164, 10.1111/imr.12841 Willoughby, 2007, Raf signaling but not the ERK effector SAP-1 is required for regulatory T cell development, J. Immunol., 179, 6836, 10.4049/jimmunol.179.10.6836 Huynh, 2014, Signals and pathways controlling regulatory T cells, Immunol. Rev., 258, 117, 10.1111/imr.12148 Yan, 2020, The function and role of the Th17/Treg cell balance in inflammatory bowel disease, J. Immunol. Res., 2020 Zhang, 2021, Bach2 attenuates IL-2R signaling to control Treg homeostasis and Tfr development, Cell Rep., 35, 10.1016/j.celrep.2021.109096 Roychoudhuri, 2013, BACH2 represses effector programs to stabilize Treg-mediated immune homeostasis, Nature, 498, 506, 10.1038/nature12199 Cretney, 2011, The transcription factors Blimp-1 and IRF4 jointly control the differentiation and function of effector regulatory T cells, Nat. Immunol., 12, 304, 10.1038/ni.2006 Sidwell, 2020, Attenuation of TCR-induced transcription by Bach2 controls regulatory T cell differentiation and homeostasis, Nat. Commun., 11, 252, 10.1038/s41467-019-14112-2 Sasikala, 2018, Bach2 repression mediates Th17 cell induced inflammation and associates with clinical features of advanced disease in chronic pancreatitis, United Eur. Gastroenterol. J., 6, 272, 10.1177/2050640617716596 Yang, 2020, Protein kinase 2 (CK2) controls CD4+ T cell effector function in the pathogenesis of colitis, Mucosal. Immunol., 13, 788, 10.1038/s41385-020-0258-x Guy, 2009, Organization of proximal signal initiation at the TCR: CD3 complex, Immunol. Rev., 232, 7, 10.1111/j.1600-065X.2009.00843.x Sharpe, 2009, Mechanisms of costimulation, Immunol. Rev., 229, 5, 10.1111/j.1600-065X.2009.00784.x Porciello, 2016, CD28 costimulatory signals in T lymphocyte activation: emerging functions beyond a qualitative and quantitative support to TCR signalling, Cytokine Growth Factor Rev., 28, 11, 10.1016/j.cytogfr.2016.02.004 Park, 2005, A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17, Nat. Immunol., 6, 1133, 10.1038/ni1261 Liao, 2011, Modulation of cytokine receptors by IL-2 broadly regulates differentiation into helper T cell lineages, Nat. Immunol., 12, 551, 10.1038/ni.2030 Zhu, 2020, The correlation between the Th17/Treg cell balance and bone health, Immun. Ageing, 17, 1, 10.1186/s12979-020-00202-z Bouguermouh, 2009, CD28 co-stimulation down regulates Th17 development, PLoS One, 4, e5087, 10.1371/journal.pone.0005087 Revu, 2018, IL-23 and IL-1β drive human Th17 cell differentiation and metabolic reprogramming in absence of CD28 costimulation, Cell Rep., 22, 2642, 10.1016/j.celrep.2018.02.044 Tai, 2005, CD28 costimulation of developing thymocytes induces Foxp3 expression and regulatory T cell differentiation independently of interleukin 2, Nat. Immunol., 6, 152, 10.1038/ni1160 Kim, 2021, In vivo induction of regulatory T Cells Via CTLA-4 signaling peptide to control autoimmune encephalomyelitis and prevent disease relapse, Adv. Sci., 8 Keir, 2008, PD-1 and its ligands in tolerance and immunity, Annu. Rev. Immunol., 26, 677, 10.1146/annurev.immunol.26.021607.090331 Wang, 2018, Percentages of PD-1+ CD4+ T cells and PD-L1+ DCs are increased and sPD-1 level is elevated in patients with immune thrombocytopenia, Hum. Vaccin. Immunother., 14, 832, 10.1080/21645515.2017.1342913 Zhong, 2016, Lower expression of PD-1 and PD-L1 in peripheral blood from patients with chronic ITP, Hematology, 21, 552, 10.1080/10245332.2016.1155347 Wu, 2019, PD-1/PD-L1 pathway activation restores the imbalance of Th1/Th2 and treg/Th17 cells subtypes in immune thrombocytopenic purpura patients, Medicine, 98, 10.1097/MD.0000000000017608 Nie, 2019, PD-1/PD-L pathway potentially involved in ITP immunopathogenesis, Thromb. Haemost., 119, 758, 10.1055/s-0039-1679909 Kawaguchi, 2021, Notch signaling and liver cancer, 69 Yamaguchi, 2002, Expression of Notch ligands, Jagged1, 2 and Delta1 in antigen presenting cells in mice, Immunol. Lett., 81, 59, 10.1016/S0165-2478(01)00326-1 Ma, 2010, Aberrant expression of Notch signaling molecules in patients with immune thrombocytopenic purpura, Ann. Hematol., 89, 155, 10.1007/s00277-009-0790-y Gawdat, 2016, Correlation of Notch1/Hes1 genes expression levels in Egyptian paediatric patients with newly diagnosed and persistent primary immune (idiopathic) thrombocytopenic purpura, Indian J. Hematol. Blood Transfus, 32, 362, 10.1007/s12288-015-0570-x Li, 2018, Th17/Treg dysregulation in allergic asthmatic children is associated with elevated notch expression, J. Asthma, 55, 1, 10.1080/02770903.2016.1266494 Yu, 2021, Decreasing lncRNA PVT1 causes Treg/Th17 imbalance via NOTCH signaling in immune thrombocytopenia, Hematology, 26, 734, 10.1080/16078454.2021.1974200 Ghetti, 2020, Linear and circular PVT1 in hematological malignancies and immune response: two faces of the same coin, Mol. Cancer, 19, 1, 10.1186/s12943-020-01187-5 Zuo, 2017, Plasma microRNAs characterising patients with immune thrombo cytopenic purpura, Thromb. Haemost., 117, 1420, 10.1160/TH-16-06-0481 Jernås, 2013, MicroRNA regulate immunological pathways in T-cells in immune thrombocytopenia (ITP), Blood, 121, 2095, 10.1182/blood-2012-12-471250 Jafarzadeh, 2021, Dysregulated expression of miRNAs in immune thrombocytopenia, Epigenomics, 13, 1317, 10.2217/epi-2021-0092 Liu, 2016, The aberrant expression of microRNAs and correlations with T cell subsets in patients with immune thrombocytopenia, OncoTargets Ther., 7, 76453, 10.18632/oncotarget.12949 Wang, 2022, Expression of miR-106b-5p in children with primary immune thrombocytopenia and its correlation with T cells. Zhongguo Dang dai er ke za zhi=, Zhongguo Dang Dai Er Ke Za Zhi, 24, 411 Li, 2020, miR-106b-5p induces immune imbalance of Treg/Th17 in immune thrombocytopenic purpura through NR4A3/Foxp3 pathway, Cell Cycle, 19, 1265, 10.1080/15384101.2020.1746485 He, 2021, Bone marrow mesenchymal stem cell-derived exosomes induce the Th17/Treg imbalance in immune thrombocytopenia through miR-146a-5p/IRAK1 axis, Hum. Cell, 34, 1360, 10.1007/s13577-021-00547-7 Li, 2015, MicroRNA-125-5p targeted CXCL13: a potential biomarker associated with immune thrombocytopenia, Am. J. Transl. Res., 7, 772 Li, 2016, Long non-coding RNA MEG3 inhibits microRNA-125a-5p expression and induces immune imbalance of Treg/Th17 in immune thrombocytopenic purpura, Biomed. Pharmacother., 83, 905, 10.1016/j.biopha.2016.07.057 Wu, 2020, Pathogenesis of immune thrombocytopenic Purpura (ITP) by MiRNA-30a-mediated Th17 cell differentiation, Zhongguo Shi Yan Xue Ye Xue Za Zhi, 28, 588 Zhao, 2022, The extensive regulation of MicroRNA in immune thrombocytopenia, Clin. Appl. Thromb. Hemost., 28, 10.1177/10760296221093595 Li, 2021, Extracellular vesicles derived from miR-199a-5p-modified adipose-derived mesenchymal stem cells alleviate immune thrombocytopenia by inhibiting T helper 17 differentiation, Lab. Invest., 101, 318, 10.1038/s41374-020-00515-z Hirano, 2019, Forced expression of NR4A3 induced the differentiation of human neuroblastoma-derived NB1 cells, Med. Oncol., 36, 1, 10.1007/s12032-019-1289-6 Close, 2019, The orphan nuclear receptor Nor1/Nr4a3 is a negative regulator of β-cell mass, J. Biol. Chem., 294, 4889, 10.1074/jbc.RA118.005135 Sekiya, 2013, Nr4a receptors are essential for thymic regulatory T cell development and immune homeostasis, Nat. Immunol., 14, 230, 10.1038/ni.2520 He, 2020, miR‑106b‑5p promotes cell proliferation and cell cycle progression by directly targeting CDKN1A in osteosarcoma, Exp. Ther. Med., 19, 3203 Qian, 2018, Differential expression of MiR-106b-5p and MiR-200c-3p in newly diagnosed versus chronic primary immune thrombocytopenia patients based on systematic analysis, Cell. Physiol. Biochem., 45, 301, 10.1159/000486811 Gu, 2021, miR-99a regulates CD4+ T cell differentiation and attenuates experimental autoimmune encephalomyelitis by mTOR-mediated glycolysis, Mol. Ther. Nucleic Acids, 26, 1173, 10.1016/j.omtn.2021.07.010 Warth, 2015, Induced miR-99a expression represses Mtor cooperatively with miR-150 to promote regulatory T-cell differentiation, EMBO J., 34, 1195, 10.15252/embj.201489589 He, 2020, Th17/Treg imbalance and atherosclerosis, Dis. Markers, 2020 Durant, 2010, Diverse targets of the transcription factor STAT3 contribute to T cell pathogenicity and homeostasis, Immunity, 32, 605, 10.1016/j.immuni.2010.05.003 Knochelmann, 2018, When worlds collide: th17 and Treg cells in cancer and autoimmunity, Cell Mol. Immunol., 15, 458, 10.1038/s41423-018-0004-4 Le Menn, 2022, The effects of post-translational modifications on Th17/Treg cell differentiation, Biochim. Biophys. Acta., 10.1016/j.bbamcr.2022.119223 Wanke, 2018, Expression of IL-17F is associated with non-pathogenic Th17 cells, J. Mol. Med., 96, 819, 10.1007/s00109-018-1662-5 Takimoto, 2010, Smad2 and Smad3 are redundantly essential for the TGF-β–mediated regulation of regulatory T plasticity and Th1 development, J. Immunol., 185, 842, 10.4049/jimmunol.0904100 Wang, 2021, Decreased levels of immune-regulatory cytokines in patients with immune thrombocytopenia and long-lasting overexpression of these cytokines in the splenectomized patients, J. Leukoc. Biol., 110, 335, 10.1002/JLB.5AB0521-621RR Ma, 2014, The cytokines (IFN-γ, IL-2, IL-4, IL-10, IL-17) and Treg cytokine (TGF-β1) levels in adults with immune thrombocytopenia, Die Pharmazie, 69, 694 Wang, 2011, Reduced expression of transforming growth factor-β1 and correlated elevation of interleukin-17 and interferon-γ in pediatric patients with chronic primary immune thrombocytopenia (ITP), Pediatr. Blood. Cancer, 57, 636, 10.1002/pbc.22984 He, 2018, Mesenchymal stem cell deficiency influences megakaryocytopoiesis through the TNFAIP 3/NF-κB/SMAD pathway in patients with immune thrombocytopenia, Br. J. Haematol., 180, 395, 10.1111/bjh.15034 Hu, 2021, Expression and function of Smad7 in autoimmune and inflammatory diseases, J. Mol. Med., 99, 1209, 10.1007/s00109-021-02083-1 Dubin, 2009, Interleukin-17A and interleukin-17F: a tale of two cytokines, Immunity, 30, 9, 10.1016/j.immuni.2008.12.010 Li, 2008, Elevated expression of IL-17 and IL-23 in patients with immune thrombocytopenic purpura, Blood, 112, 4537, 10.1182/blood.V112.11.4537.4537 Ye, 2015, The role of IL-23/Th17 pathway in patients with primary immune thrombocytopenia, PLoS One, 10, 10.1371/journal.pone.0117704 Zhou, 2007, IL-6 programs TH-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways, Nat. Immunol., 8, 967, 10.1038/ni1488 Floss, 2015, Insights into IL-23 biology: from structure to function, Cytokine Growth Factor Rev., 26, 569, 10.1016/j.cytogfr.2015.07.005 Stritesky, 2008, IL-23 promotes maintenance but not commitment to the Th17 lineage, J. Immunol., 181, 5948, 10.4049/jimmunol.181.9.5948 Abdo, 2020, Interleukin 23 and autoimmune diseases: current and possible future therapies, Inflamm. Res., 69, 463, 10.1007/s00011-020-01339-9 Chang, 2013, MyD88 is essential to sustain mTOR activation necessary to promote T helper 17 cell proliferation by linking IL-1 and IL-23 signaling, Proc. Natl. Acad. Sci., 110, 2270, 10.1073/pnas.1206048110 Zhang, 2014, Increased percentages of T cells producing interleukin-21 in patients with immune thrombocytopenic purpura, Cell Biol. Int., 38, 520, 10.1002/cbin.10220 Zhang, 2015, Effects of the interleukin-21 expression in patients with immune thrombocytopenia and its regulation by high-dose dexamethasone, Zhongguo Shi Yan Xue Ye Xue Za Zhi, 23, 465 Wei, 2007, IL-21 is produced by Th17 cells and drives IL-17 production in a STAT3-dependent manner, J. Biol. Chem., 282, 34605, 10.1074/jbc.M705100200 Shi, 2019, IL-21 induces an imbalance of Th17/Treg cells in moderate-to-severe plaque psoriasis patients, Front. Immunol., 10, 1865, 10.3389/fimmu.2019.01865 Bayer, 2005, Essential role for interleukin-2 for CD4+ CD25+ T regulatory cell development during the neonatal period, J. Exp. Med., 201, 769, 10.1084/jem.20041179 Burchill, 2007, IL-2 receptor β-dependent STAT5 activation is required for the development of Foxp3+ regulatory T cells, J. Immunol., 178, 280, 10.4049/jimmunol.178.1.280 Vang, 2008, IL-2,-7, and-15, but not thymic stromal lymphopoeitin, redundantly govern CD4+ Foxp3+ regulatory T cell development, J. Immunol., 181, 3285, 10.4049/jimmunol.181.5.3285 Marshall, 2014, Differential requirement for IL-2 and IL-15 during bifurcated development of thymic regulatory T cells, J. Immunol., 193, 5525, 10.4049/jimmunol.1402144 Apert, 2022, IL-2 and IL-15 drive intrathymic development of distinct periphery-seeding CD4+ Foxp3+ regulatory T lymphocytes, Front. Immunol., 4919 Rashed, 2004, Serum IL-2 and platelet-associated immunoglobulins are good prognostic markers in immune thrombocytopenic purpura, Egypt. J. Immunol., 11, 121 Laurent, 2021, Interleukin-15 enhances proinflammatory T-cell responses in patients with MS and EAE, Neurol. Neuroimmunol. Neuroinflamm., 8, 10.1212/NXI.0000000000000931 Goelz, 2020, Increased levels of IL-10 and IL-1Ra counterbalance the proinflammatory cytokine pattern in acute pediatric immune thrombocytopenia, Cytokine, 130, 10.1016/j.cyto.2020.155078 Lazarus, 2000, Comparison of platelet immunity in patients with SLE and with ITP, Transfus. Sci., 22, 19, 10.1016/S0955-3886(00)00004-7 Jones, 2020, Dynamic roles for IL-2–STAT5 signaling in effector and regulatory CD4+ T cell populations, J. Immunol., 205, 1721, 10.4049/jimmunol.2000612 Tosiek, 2016, IL-15-dependent balance between Foxp3 and RORγt expression impacts inflammatory bowel disease, Nat. Commun., 7, 10888, 10.1038/ncomms10888 Ling, 2007, Circulating dendritic cells subsets and CD4+ Foxp3+ regulatory T cells in adult patients with chronic ITP before and after treatment with high-dose dexamethasome, Eur. J. Haematol., 79, 310, 10.1111/j.1600-0609.2007.00917.x Guo, 2007, Correction of Th1-dominant cytokine profiles by high-dose dexamethasone in patients with chronic idiopathic thrombocytopenic purpura, J. Clin. Immunol., 27, 557, 10.1007/s10875-007-9111-1 Li, 2020, Dexamethasone suppresses the Th17/1 cell polarization in the CD4+ T cells from patients with primary immune thrombocytopenia, Thromb. Res., 190, 26, 10.1016/j.thromres.2020.04.004 Yan, 2023, Research on the mechanism of prednisone in the treatment of ITP via VIP/PACAP-mediated intestinal immune dysfunction, Eur. J. Med. Res., 28, 1, 10.1186/s40001-023-00987-x Kapur, 2020, Thrombopoietin receptor agonist (TPO-RA) treatment raises platelet counts and reduces anti-platelet antibody levels in mice with immune thrombocytopenia (ITP), Platelets., 31, 399, 10.1080/09537104.2019.1624709 M-m, 2017, Cytokine changes in response to TPO receptor agonist treatment in primary immune thrombocytopenia, Cytokine, 92, 110, 10.1016/j.cyto.2017.01.013 Bao, 2010, Improved regulatory T-cell activity in patients with chronic immune thrombocytopenia treated with thrombopoietic agents, Blood, 116, 4639, 10.1182/blood-2010-04-281717 Schifferli, 2016, Thrombopoietin receptor agonists: a new immune modulatory strategy in immune thrombocytopenia? Stasi, 2008, Analysis of regulatory T-cell changes in patients with idiopathic thrombocytopenic purpura receiving B cell–depleting therapy with rituximab, Blood, 112, 1147, 10.1182/blood-2007-12-129262 Li, 2011, Low-dose rituximab combined with short-term glucocorticoids up-regulates Treg cell levels in patients with immune thrombocytopenia, Int. J. Hematol., 93, 91, 10.1007/s12185-010-0753-z Crow, 2013, Amelioration of murine passive immune thrombocytopenia by IVIg and a therapeutic monoclonal CD44 antibody does not require the Myd88 signaling pathway, PLoS One, 8, e71882, 10.1371/journal.pone.0071882 Kessel, 2007, Intravenous immunoglobulin therapy affects T regulatory cells by increasing their suppressive function, J. Immunol., 179, 5571, 10.4049/jimmunol.179.8.5571 Maddur, 2011, Comparison of different IVIg preparations on IL-17 production by human Th17 cells, Autoimmun. Rev., 10, 809, 10.1016/j.autrev.2011.02.007 Maddur, 2013, Inhibitory effect of IVIG on IL-17 production by Th17 cells is independent of anti-IL-17 antibodies in the immunoglobulin preparations, J. Clin. Immunol., 33, 62, 10.1007/s10875-012-9752-6 Wang, 2020, Intravenous immunoglobulin therapy enhances suppressive regulatory T cells and decreases innate lymphoid cells in children with immune thrombocytopenia, Pediatr. Blood. Cancer, 67, e28075, 10.1002/pbc.28075 Guo, 2019, The potential therapeutic benefit of resveratrol on Th17/Treg imbalance in immune thrombocytopenic purpura, Int. Immunopharmacol., 73, 181, 10.1016/j.intimp.2019.04.061 Zhang, 2018, Low dose IL-2 increase regulatory T cells and elevate platelets in a patient with immune thrombocytopenia, Cytometry Part B, 94, 400, 10.1002/cyto.b.21494